SPARC Schedules Board Meeting on 2nd Nov'26 to Consider Q2 FY27 Results
Sun Pharma Advanced Research Company Ltd 路 Intimation 路 02 Nov 2026, 5:30 am
SPARC Schedules Board Meeting on 2nd Nov'26 to Consider Q2 FY27 Results Sun Pharma Advanced Research Company Ltd (SPARC) has scheduled a Board of Directors meeting for 2nd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed for designated persons starting 1st Oct'26 and will remain closed until 48 hours after the declaration and submission of the financial results to stock exchanges.
Original exchange filing (PDF)
More announcements from Sun Pharma Advanced Research Company Ltd
- Receipt of No- Objection Letters from the Stock Exchanges for Reclassification of Promoter Group 路 12 Nov 2026
- Response of Clarification sought from BSE Limited 路 11 Nov 2026
- The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on November 11, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. 路 11 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 路 03 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 03 Nov 2026
- Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the unaudited financial results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Sun Pharma Advanced Research Company Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 02 Nov 2026
- To consider and approve the financial results for the quarter and half year ended September 30, 2026 路 02 Nov 2026
